Literature DB >> 16932993

Postnatal iron overload destroys NA-DA functional interactions.

A Fredriksson1, T Archer.   

Abstract

C57/BL6 mice were administered either postnatal iron (Fe(2+) 7.5 mg/kg, on postnatal days 10-12) or vehicle, followed by administration of either DSP4 (50 mg/kg, s.c., 30 min after injection of zimeldine, 20 mg/kg, s.c.) or vehicle (saline) at 63 days of age. Three weeks later, iron/vehicle treated, DSP4/vehicle treated mice were injected with either a low dose of MPTP (2 x 20 mg/kg, with a 24-hr interval between injections) or vehicle. Behaviour testing took place a further three weeks (spontaneous behaviour and L-Dopa induced) and two weeks (clonidine-L-Dopa induced) later. Postnatal iron administration exacerbated the bradykinesia induced by MPTP and virtually abolished all spontaneous motor activity in NA-denervated mice that were MPTP-treated. Postnatal iron administration reduced markedly the restoration of motor activity by suprathreshold L-Dopa (20 mg/kg) following a 60-min habituation to the test chambers. Pretreatment with DSP4 effectively eliminated the restorative effect of L-Dopa in the MPTP mice. The synergistic effects of co-administration of clinidine (1 mg/kg) with a subthreshold dose of L-Dopa (5 mg/kg) in elevating the motor activity of MPTP mice were reduced markedly by postnatal iron administration, as well as by pretreatment with DSP4. NA-denervation by DSP4, after postnatal iron treatment, totally abolished the activity-elevating effects of the alpha-adrenoceptor agonist + DA-precursor combination in MPTP mice, and virtually eliminated these effects in saline (non-MPTP) mice. Postnatal iron administration caused enduring higher levels of total iron content in all the groups with an increased level in mice treated with DSP4 followed by MPTP. These divergent findings confirm the direct influence of NA innervation upon dopaminergic functional expression and indicate a permanent vulnerability both in the noradrenergic and dopaminergic pathways following the postnatal infliction of an iron overload.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932993     DOI: 10.1007/s00702-006-0522-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  39 in total

1.  MPTP-induced hypoactivity in mice: reversal by L-dopa.

Authors:  A Fredriksson; A Plaznik; E Sundström; G Jonsson; T Archer
Journal:  Pharmacol Toxicol       Date:  1990-10

2.  Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Behav Brain Res       Date:  2003-02-17       Impact factor: 3.332

3.  Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.

Authors:  M Marien; M Briley; F Colpaert
Journal:  Eur J Pharmacol       Date:  1993-06-04       Impact factor: 4.432

4.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

Review 5.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

Authors:  R E Heikkila; B A Sieber; L Manzino; P K Sonsalla
Journal:  Mol Chem Neuropathol       Date:  1989-06

6.  Serotonin and fear retention in the rat.

Authors:  T Archer
Journal:  J Comp Physiol Psychol       Date:  1982-06

7.  Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.

Authors:  D J Dooley; E Mogilnicka; A Delini-Stula; F Waechter; A Truog; J Wood
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 8.  Noradrenergic mechanisms in neurodegenerative diseases: a theory.

Authors:  Marc R Marien; Francis C Colpaert; Alan C Rosenquist
Journal:  Brain Res Brain Res Rev       Date:  2004-04

9.  Alteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin.

Authors:  D J Dooley; H Bittiger; K L Hauser; S F Bischoff; P C Waldmeier
Journal:  Neuroscience       Date:  1983-08       Impact factor: 3.590

10.  DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

Authors:  G Jonsson; H Hallman; F Ponzio; S Ross
Journal:  Eur J Pharmacol       Date:  1981-06-19       Impact factor: 4.432

View more
  3 in total

1.  Physical exercise attenuates MPTP-induced deficits in mice.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2010-03-19       Impact factor: 3.911

2.  Running wheel activity restores MPTP-induced functional deficits.

Authors:  Anders Fredriksson; Ingels Maria Stigsdotter; Anders Hurtig; Béatrice Ewalds-Kvist; Trevor Archer
Journal:  J Neural Transm (Vienna)       Date:  2010-09-18       Impact factor: 3.575

3.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.